Gloria Galimberti

Summary

Affiliation: University of Milano-Bicocca
Country: Italy

Publications

  1. doi request reprint Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?
    Gloria Galimberti
    Department of Neuroscience and Biomedical Technology, University of Milano Bicocca, Via Cadore 48, 20052 Monza MI, Italy
    Clin Biochem 41:914-6. 2008
  2. doi request reprint Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients
    Elisa Conti
    Department of Neuroscience and Biomedical Technologies, University of Milano Bicocca, San Gerardo Hospital, Via Cadore 48, 20052 Monza MI, Italy
    Neurosci Lett 486:193-6. 2010
  3. doi request reprint Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease
    Fabrizio Piazza
    Department of Neuroscience and Biomedical Technologies, University of Milano Bicocca, Monza MI, Italy
    Neurobiol Aging 33:226-33. 2012
  4. ncbi request reprint Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake
    Angelo Aliprandi
    Department of Neuroscience and Biomedical Technologies, University of Milano Bicocca, Monza MI, Italy
    J Cereb Blood Flow Metab 25:513-9. 2005
  5. ncbi request reprint Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease
    Chiara Zoia
    Department of Neuroscience and Biomedical Technology, University of Milano Bicocca, 20052 Mi, Monza, Italy
    Neurobiol Aging 25:149-57. 2004
  6. doi request reprint Increased soluble APPalpha, Abeta 1-42, and anti-Abeta 1-42 antibodies in plasma from down syndrome patients
    Elisa Conti
    Department of Neuroscience and Biomedical Technologies, San Gerardo Hospital, University of Milano Bicocca, Monza, Italy
    Alzheimer Dis Assoc Disord 24:96-100. 2010
  7. doi request reprint Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients
    Emanuela Cazzaniga
    Department of Experimental Medicine, University of Milano Bicocca Via Cadore 48, 20052 Monza, MI, Italy
    Neurosci Lett 436:317-20. 2008
  8. doi request reprint Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients
    Lucio Tremolizzo
    Dept of Neurology, S Gerardo Hospital, University of Milano Bicocca, Monza, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 39:47-51. 2012
  9. ncbi request reprint Peripheral cytokine release in Alzheimer patients: correlation with disease severity
    Gessica Sala
    Department of Neurology, University of Milano Bicocca, San Gerardo Hospital, Via Donizetti, 106, Monza 20052 MI, Italy
    Neurobiol Aging 24:909-14. 2003
  10. pmc Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In Vitro
    Alessandro Cinti
    Department of Surgery and Translational Medicine, University of Milano Bicocca, Monza, Italy
    PLoS ONE 10:e0141933. 2015

Collaborators

  • Elisa Conti
  • Gessica Sala
  • V Isella
  • Tiziana Cogliati
  • Jacopo C DiFrancesco
  • Laura Antolini
  • Barbara Borroni
  • I Appollonio
  • M Pitto
  • Carlo Ferrarese
  • Daniela Galimberti
  • E Scarpini
  • Roberto Del Bo
  • Lucio Tremolizzo
  • Alessandro Cinti
  • Fabrizio Piazza
  • Ilaria Rivolta
  • Emanuela Cazzaniga
  • Angelo Aliprandi
  • Carmen Galbusera
  • Chiara Zoia
  • Marco De Giorgi
  • Marialuisa Lavitrano
  • Roberto Giovannoni
  • Cristina Bugarin
  • Maria Grazia Cerrito
  • Laura Farina
  • Giuseppe Gaipa
  • Ryszard Tom Smolenski
  • Claudia Arena
  • Elisa Chisci
  • Maria V Perlangeli
  • Alessandro Padovani
  • Enrico M Pogliani
  • Chiara Riva
  • Claudio Ruffmann
  • Tiziana Speranza
  • Virginia Rodriguez-Menendez
  • Alessandra Bulbarelli
  • Massimo Masserini
  • Francesca Re
  • Elena Lonati
  • Elena Gatti
  • Marco Longoni
  • Manuela Vaccaro
  • Barbara Begni
  • Rosanna Garofolo
  • Lorenzo Stanzani
  • Franca Rosa Guerini
  • Lodovico Frattola
  • Fulvio Magni
  • Elena Tagliabue
  • Lucia Tremolada
  • Vincenzo Rossi
  • Guido Cavaletti
  • Marzia Galli-Kienle
  • Maurizio Facheris

Detail Information

Publications13

  1. doi request reprint Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?
    Gloria Galimberti
    Department of Neuroscience and Biomedical Technology, University of Milano Bicocca, Via Cadore 48, 20052 Monza MI, Italy
    Clin Biochem 41:914-6. 2008
    ..To identify the real number of hyperhomocysteinemic Alzheimer's patients who may benefit from homocysteine-lowering therapy...
  2. doi request reprint Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients
    Elisa Conti
    Department of Neuroscience and Biomedical Technologies, University of Milano Bicocca, San Gerardo Hospital, Via Cadore 48, 20052 Monza MI, Italy
    Neurosci Lett 486:193-6. 2010
    ..We suggest that a strategy aimed at increasing the endogenous response against this peptide might represent an interesting therapeutic target to be further investigated...
  3. doi request reprint Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease
    Fabrizio Piazza
    Department of Neuroscience and Biomedical Technologies, University of Milano Bicocca, Monza MI, Italy
    Neurobiol Aging 33:226-33. 2012
    ..Therefore, TFPI may represent a candidate marker of endothelial damage in AD and might be used for the identification and monitoring of patients that would benefit from folate supplementation treatment...
  4. ncbi request reprint Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake
    Angelo Aliprandi
    Department of Neuroscience and Biomedical Technologies, University of Milano Bicocca, Monza MI, Italy
    J Cereb Blood Flow Metab 25:513-9. 2005
    ..Our data show a prolonged increase of glutamate in plasma after stroke, which might presumably be linked to altered platelet functions, such as excessive release of the amino acid or impaired uptake...
  5. ncbi request reprint Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease
    Chiara Zoia
    Department of Neuroscience and Biomedical Technology, University of Milano Bicocca, 20052 Mi, Monza, Italy
    Neurobiol Aging 25:149-57. 2004
    ..Platelet glutamate transporters may be used as peripheral markers to investigate the role of glutamate in patients with neuropsychiatric disorders...
  6. doi request reprint Increased soluble APPalpha, Abeta 1-42, and anti-Abeta 1-42 antibodies in plasma from down syndrome patients
    Elisa Conti
    Department of Neuroscience and Biomedical Technologies, San Gerardo Hospital, University of Milano Bicocca, Monza, Italy
    Alzheimer Dis Assoc Disord 24:96-100. 2010
    ..Our results suggested sAPPalpha as a possible peripheral marker for the alteration in APP metabolism in DS and highlighted an alteration in anti-abeta antibodies, for the first time evaluated in plasma from DS subjects...
  7. doi request reprint Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients
    Emanuela Cazzaniga
    Department of Experimental Medicine, University of Milano Bicocca Via Cadore 48, 20052 Monza, MI, Italy
    Neurosci Lett 436:317-20. 2008
    ..01; n=8) higher (2-4-fold) with respect to controls. RT-PCR experiments suggest that the higher folate binding could be due to an enhanced expression in AD fibroblasts of folate receptor alpha...
  8. doi request reprint Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients
    Lucio Tremolizzo
    Dept of Neurology, S Gerardo Hospital, University of Milano Bicocca, Monza, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 39:47-51. 2012
    ..We suggest that the epigenetic properties of VPA expressed on PBMC at these concentrations might be operative in different tissues, with possible implications for the field of neuropsychiatric disorders...
  9. ncbi request reprint Peripheral cytokine release in Alzheimer patients: correlation with disease severity
    Gessica Sala
    Department of Neurology, University of Milano Bicocca, San Gerardo Hospital, Via Donizetti, 106, Monza 20052 MI, Italy
    Neurobiol Aging 24:909-14. 2003
    ..IL-1beta, IL-6 and TNF-alpha secretion was negatively correlated with the severity of dementia, quantified by the MMSE. Our data suggest that alterations of the immune profile are associated with AD progression...
  10. pmc Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In Vitro
    Alessandro Cinti
    Department of Surgery and Translational Medicine, University of Milano Bicocca, Monza, Italy
    PLoS ONE 10:e0141933. 2015
    ..These results could provide new insights in the research of protective mechanisms in transplantation settings. ..
  11. ncbi request reprint Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis
    Roberto Del Bo
    Dino Ferrari Centre, Department of Neurological Sciences, University of Milan and Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Padiglione Ponti, Milano, Italy
    Neurobiol Aging 27:770.e1-770.e5. 2006
    ..We also observed that MM genotype and M allele represent a risk factor for AD, independently from the ethnic background, providing a significant but modest association between this polymorphism and AD...
  12. ncbi request reprint Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients
    Carmen Galbusera
    Department of Neuroscience and Biomedical Technologies, University of Milano, Bicocca, Milan, Italy
    Curr Alzheimer Res 1:103-9. 2004
    ..Thus, oxidative stress, expressed as ex vivo susceptibility to lipid peroxidation, appears to be an early phenomenon, probably related to AD pathogenetic mechanisms...
  13. ncbi request reprint Vascular endothelial growth factor gene variability is associated with increased risk for AD
    Roberto Del Bo
    Department of Neurological Sciences, Dino Ferrari Centre and Centre of Excellence on Neurodegenerative Diseases, University of Milan, I R C C S Ospedale Maggiore Policlinico, Via F Sforza 35, 20122 Milan, Italy
    Ann Neurol 57:373-80. 2005
    ..These findings suggest that polymorphisms within the promoter region of the VEGF gene confer greater risk for AD, probably by reducing its neuroprotective effect, and confirm the biological role of VEGF in neurodegenerative processes...